How many insider declarations has AH Bio Fund IV, L.P. filed?

AH Bio Fund IV, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is AH Bio Fund IV, L.P.'s role?

AH Bio Fund IV, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does AH Bio Fund IV, L.P. report trades for?

AH Bio Fund IV, L.P. reports trades for Braveheart Bio, Inc..

What is AH Bio Fund IV, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 17.2M€ and disposals 0.

← Executives ★ Sign in to follow

AB

AH Bio Fund IV, L.P.

·SEC (Form 4)

Braveheart Bio, Inc.

0

申报总数

0

公司

€1718万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by AH Bio Fund IV, L.P.. Director active across 1 company, notably Braveheart Bio, Inc.. Cumulatively, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €17.2m. Activity tracked since 7 August 2026. The latest transaction was disclosed on 7 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to AH Bio Fund IV, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Braveheart Bio, Inc. (US)

申报2 总计

●

AH Bio Fund IV, L.P.

10% Owner高管2026年8月7日Braveheart Bio, Inc.

0SEC ↗

9,132,420 股Common StockSEC:0001231919-26-000859:0

▲

AH Bio Fund IV, L.P.

10% Owner高管2026年8月7日Braveheart Bio, Inc.

US$1980万0SEC ↗

1,100,000 股@ US$18.00Common StockSEC:0001231919-26-000859:1

标准退出：2026年11月5日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AB

AH Bio Fund IV, L.P.

·SEC (Form 4)

Braveheart Bio, Inc.

0

申报总数

0

公司

€1718万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by AH Bio Fund IV, L.P.. Director active across 1 company, notably Braveheart Bio, Inc.. Cumulatively, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €17.2m. Activity tracked since 7 August 2026. The latest transaction was disclosed on 7 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.